Travel site Trip.com to raise $8.47b in global offering

It priced its offer shares at $268.

Hong Kong-listed Trip.com Group Limited announced its final offer prices for its global offering at $268 per offer share.

The gross proceeds from the international and Hong Kong public offering to the Company is expected at around $8.47b, before offering expenses and underwriting fees are deducted.

The company noted its ordinary shares are set to begin trading on the Main Board of the Hong Kong Stock Exchange (HKEx) on 19 April, subject to HKEx approval.

Further, proceeds will be used for the expansion of the company’s one-stop travel offerings as well as to improve user experience.

The company also plans to invest in technology to boost its leading market position in products and services. It is also seen to improve their operating efficiency.

In an earlier announcement, the company said it will sell more than 31.6m shares. Of this, 2.2m are for Hong Kong offering, whilst 29.4 will be for its international offering.

Aside from Trip.com, the Group also consists of other one-stop travel service platforms Skyscanner and Qunar.
 

Join Hong Kong Business community
Since you're here...

...there are many ways you can work with us to advertise your company and connect to your customers. Our team can help you dight and create an advertising campaign, in print and digital, on this website and in print magazine.

We can also organize a real life or digital event for you and find thought leader speakers as well as industry leaders, who could be your potential partners, to join the event. We also run some awards programmes which give you an opportunity to be recognized for your achievements during the year and you can join this as a participant or a sponsor.

Let us help you drive your business forward with a good partnership!

Exclusives

Hong Kong Residency rule could boost office sector
The ultra-rich are also expected to set up family offices in the city.
Allegrow Biotech engineers technology to activate immune cells
The startup’s invention can be used to treat and potentially cure diseases like cancer.
Healthcare
Renminbi rise to fuel Bank of China HK’s growth
The lender expects the currency to be used more often in cross-border deals.
Retail Banking